View Author
patient hepatitis hepatitis b treatment hbsag study level response therapy resistance hepatology virus baseline liver serum disease cirrhosis hbv dna month ef ficacy hbeag diabetes mellitus hepatitis c infection hepatitis b virus virological virological response entecavir analysis adefovir diabetes hbv dna levels combination monotherapy follow-up lamivudine group tenofovir health european mellitu etv monotherapy probability ficacy decline liver disease gastroenterology department range mutation screening hepatocellular carcinoma hbeag-negative population factor peginterferon signi combination therapy table genotypic hbsag loss tdf monotherapy virologic response roche virologic genotype europe genotypic resistance hepatitis b patients fication antigen na-na vaccination hbv infection hbeag-positive effect university hbsag decline brosi hepatol
10 Most Recent Publications
|
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
(Article)
Zoutendijk, R. Reijnders, J.G.P. Berg, T. Hansen, B.E. Sonneveld, M.J. Wedemeyer, H. Janssen, H.L.A. Zoulim, F. Brown, A. Mutimer, D.J. Deterding, K. Hofmann, W.P. Petersen, J. Fasano, M. Buti, M. |
2013-05-01
|
|
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
(Article)
Petersen, J. Ratziu, V. Berg, T. Sarrazin, C. Lutgehetmann, M. Buggisch, P. Buti, M. Janssen, H.L.A. Brown, A. Lampertico, P. Schollmeyer, J. Zoulim, F. Wedemeyer, H. Sterneck, M. |
2012-03-01
|
|
Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
(Article)
Chan, H.L.-Y. Thompson, A. Locarnini, S. Janssen, H.L.A. Marcellin, P. Martinot-Peignoux, M. Piratvisuth, T. Cornberg, M. Brunetto, M.R. Tillmann, H. Kao, J.-H. Jia, J.-D. Wedemeyer, H. |
2011-11-01
|
|
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study
(Article)
Si-Ahmed, S.N. Pradat, P. Wedemeyer, H. Janssen, H.L.A. Zoulim, F. Zoutendijk, R. Buti, M. Mallet, V. Cruiziat, C. Deterding, K. Dumortier, J. Bailly, F. Esteban, R. |
2011-10-01
|
|
The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference
(Article)
Hatzakis, A. Wait, S. Esteban, R. Goldberg, D. Gore, C. Lok, A.S.F. Manns, M. Marcellin, P. Papatheodoridis, G. Peterle, A. Prati, D. Piorkowsky, N. Bruix, J. Rizzetto, M. Roudot-Thoraval, F. Soriano, V. Thomas, H.C. Thursz, M. Valla, D.C. Damme, P. van Veldhuizen, I.K. Wedemeyer, H. Wiessing, L. Buti, M. Zanetti, A.R. Janssen, H.L.A. Carballo, M. Cavaleri, M. Colombo, M.G. Delarocque-Astagneau, E. Dusheiko, G. Esmat, G. |
2011-09-01
|
|
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
(Article)
Zoutendijk, R. Reijnders, J.G.P. Bömmel, F. van Pradat, P. Oo, Y. Luetgehetmann, M. Berg, T. Hansen, B.E. Wedemeyer, H. Janssen, H.L.A. Brown, A. Zoulim, F. Mutimer, D. Deterding, K. Petersen, J. Hofmann, W.P. Buti, M. Santantonio, T. |
2011-08-01
|
|
Adefovir serum levels do not differ between responders and nonresponders
(Article)
Deterding, K. Naesens, L. Buti, M. Janssen, H.L.A. Kirschner, J. Guerrero, A. Reijnders, J.G.P. Neyts, J. Zoulim, F. Wedemeyer, H. |
2011-07-01
|
|
Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues
(Article)
Reijnders, J.G.P. Deterding, K. Petersen, J. Zoulim, F. Santantonio, T. Buti, M. Bömmel, F. van Hansen, B.E. Wedemeyer, H. Janssen, H.L.A. |
2010-04-01
|
|
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
(Article)
Bömmel, F. van Man, R.A. de Sarrazin, C. Böcher, W.O. Spengler, U. Wasmuth, H.E. Reinders, J.G.P. Möller, B. Rhode, P. Feucht, H.H. Wiedenmann, B. Berg, T. Wedemeyer, H. Deterding, K. Petersen, J. Buggisch, P. Erhardt, A. Hüppe, D. Stein, K. Trojan, J. |
2010-01-01
|
|
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus
(Article)
Veldt, B.J. Chen, W. Schalm, S.W. Janssen, H.L.A. Heathcote, E.J. Wedemeyer, H. Reichen, J. Hofmann, W.P. Knegt, R.J. de Zeuzem, S. Manns, M.P. Hansen, B.E. |
2008-06-01
|
